CED Clinical Relevance #50Monitored Relevance Early-stage or contextual signal requiring further evidence before action. 🔬 Evidence Watch | CED Clinic Adolescent MedicineSuicide RiskSubstance UseMental HealthCannabis JournalChildren (Basel, Switzerland)Study TypeClinical StudyPopulationHuman participants Why This MattersAdolescent substance use...
The effect of cannabis use on the time course of positive and negative affect in the daily life of youth.
CED Clinical Relevance #56Monitored Relevance Early-stage or contextual signal requiring further evidence before action. 🔬 Evidence Watch | CED Clinic YouthMoodReal-World EvidenceAdolescentsEmotional Regulation JournalPsychopharmacologyStudy TypeClinical StudyPopulationHuman participants Why This MattersThis study addresses a critical gap in...
endocannabinoid system clinical research: Eating & Youth
Clinical Takeaway Over 15 years, the REAL 2.0 cohort study tracked Canadian youth from early adolescence into early adulthood to understand how body image concerns and disordered eating behaviors in youth predict...
Endocannabinoid System Clinical Research: REAL 2.0 Findings
Clinical Takeaway The REAL 2.0 study tracked Canadian youth over 15 years to examine how early adolescent factors like body image concerns and disordered eating patterns influence mental health, eating disorders, and...
endocannabinoid system clinical research: Eating Disorders
Clinical Takeaway The REAL 2.0 cohort study tracked Canadian youth over 15 years to understand how adolescent risk factors like body image concerns and disordered eating contribute to eating disorders, mental health...
endocannabinoid system clinical research: REAL 2.0 Study
Clinical Takeaway The REAL 2.0 study tracked Canadian youth over 15 years to examine how early adolescent factors like body image and disordered eating contribute to mental health and substance use outcomes...
Endocannabinoid System & Teen Mental Health: Clinical Evidence
Clinical Takeaway Adolescents with higher levels of depression and anxiety symptoms were more likely to initiate and use cannabis more frequently over the following 18 months, supporting the idea that young people...
Adolescent Cannabis Use: Mental Health Risks Examined
Clinical Takeaway Adolescent cannabis use is associated with significantly increased risk of developing psychotic, bipolar, depressive, and anxiety disorders in adolescence and young adulthood, based on large-scale longitudinal population data. These findings...
Adolescent Cannabis Use and Psychotic Disorder Risk
Clinical Takeaway Adolescent cannabis use is associated with increased risk of developing psychotic, bipolar, depressive, and anxiety disorders in adolescence and young adulthood, based on large population-level longitudinal data tracking clinically diagnosed...
A huge study finds a link between cannabis use in teens and psychosis later – WBAA
WHY IT MATTERS: If you are a parent, caregiver, or young adult patient, this research reinforces that cannabis therapies should be reserved for adults with clinical oversight, and that adolescent use without medical necessity carries real psychiatric risk. CLINICAL OVERVIEW: Large-scale research continues to reinforce what clinicians have observed for years: adolescent cannabis use is associated with increased risk of psychotic disorders, depression, and anxiety later in life. The developing brain, particularly before age 25, is uniquely vulnerable to the effects of THC on endocannabinoid system signaling, and early exposure may alter neurodevelopmental trajectories in ways that increase psychiatric risk.